← FDA Drug Approvals (Drugs@FDA)

TAVIST-1

NDA · New Drug Application · Sponsor: HALEON US HOLDINGS · Approved 1992-08-21

Drug application

FDA Application #

NDA020925

Application type

New Drug Application

Brand name

TAVIST-1

Generic name

Clemastine Fumarate

Active ingredients

CLEMASTINE FUMARATE

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

HALEON US HOLDINGS

First approval

1992-08-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown